Pay in 4 interest-free payments of $7.33 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
Structure Therapeutics is developing GSBR-1290, an oral small molecule GLP-1 agonist that could potentially address the manufacturing scalability challenges facing peptide-based injectablesthe company has noted its current manufacturing capacity could theoretically supply over 120 million patients [46]
SwissTargetPrediction: updated data and new features for efficient prediction of protein targets of small molecules
Whether youre in our neighborhood or across the country, we can get these powerful oral peptides to you
It is one of the most cited copper peptides in dermatological and wound-research models
The mitogen-activated protein kinase (MAPK) family comprises three major subfamilies with distinct and sometimes opposing functions: extracellular signal-regulated kinase 1/2 (ERK1/2), c-Jun N-terminal kinase (JNK), and p38 MAPK
US$ 24.05
US$ 20.91
US$ 29.91
US$ 26.86
US$ 23.12
US$ 20.95
US$ 27.12
US$ 25.07
US$ 23.57
